Ruijiming Biological
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $2.5M
Investors
- 3
About Ruijiming Biological
, trading as Ruijiming Biological, operates as a biomaterial company that focuses on the production and sales of marine bioactive substances and bio-based materials. It was recognized as the National High-tech Enterprise. The company acquired the national ISO9001 system certification. It has 21 patents and 1 software copyright. Ruijiming Biological is mainly engaged in the research, development, production, and sales of regenerative medicine aesthetic raw materials, marine bioactive substances, and bio-based materials. The company has multiple GMP-grade large-scale production lines for nucleic acid raw materials. Its core products are medical and cosmetic grade marine biological raw materials - PDRN (polydeoxyribonucleotide) and PN (polynucleotide). The company generates revenue by selling marine bioactive substances and bio-based materials.
Who invested in Ruijiming Biological
3 investors across 2 rounds
See all investors in Ruijiming Biological
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ruijiming Biological
Who invested in Ruijiming Biological?
Ruijiming Biological has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruijiming Biological raised?
Ruijiming Biological has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ruijiming Biological last raise money?
Ruijiming Biological's most recent round on record is a Series B, in Apr 2026.
What does Ruijiming Biological do?
, trading as Ruijiming Biological, operates as a biomaterial company that focuses on the production and sales of marine bioactive substances and bio-based materials.
Where is Ruijiming Biological headquartered?
Ruijiming Biological is headquartered in Yantai, China.
Which VCs invest in companies like Ruijiming Biological?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back materials companies at Ruijiming Biological's stage. Their profiles are linked below.
VCs backing materials startups at Series B
Raising like Ruijiming Biological? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.